Lunai Bioworks (LNAI) Proxy filing summary

Executive summary

• Special meeting scheduled for May 4, 2026, to vote on a reverse stock split and potential adjournment if needed.

• Reverse stock split proposed at a ratio between 1-for-3 and 1-for-30, with the exact ratio to be determined by the board.

• Main goal is to increase share price to maintain Nasdaq listing and improve marketability and liquidity.

• Board retains discretion to implement or abandon the split within one year of approval.

• No cash dividends have been paid or are anticipated in the near future.

Voting matters and shareholder proposals

• Proposal 1: Approve amendment for reverse stock split at a board-determined ratio within the specified range.

• Proposal 2: Approve adjournment of the meeting if more time is needed to solicit votes for Proposal 1.

• Board recommends voting FOR both proposals.

• Abstentions count as votes against Proposal 2; broker non-votes have no effect on Proposal 1.

Board of directors and corporate governance

• Board has full discretion on the timing and ratio of the reverse stock split.

• No director or executive officer has a substantial interest in the proposals beyond their shareholdings.